| Rachel Beth Sotsky, MD | |
|
4940 Eastern Ave, Baltimore, MD 21224-2735 | |
| (410) 550-0101 | |
| (410) 550-5394 |
| Full Name | Rachel Beth Sotsky |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 16 Years |
| Location | 4940 Eastern Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174752190 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | 25MA8898300 (New Jersey) | Secondary |
| 207X00000X | Orthopaedic Surgery | D87845 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Johns Hopkins Home Health Services, Inc | Baltimore, MD | Home health agency |
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
BELLUS Health Inc. announced today that, on March 30, 2010, the Company initiated a Phase I clinical study for NRM8499, a prodrug of tramiprosate. NRM8499 is intended for the treatment of Alzheimer's disease.
University of Utah (U of U) medical researchers have uncovered a wiring diagram that shows how the brain pays attention to visual, cognitive, sensory, and motor cues. The research provides a critical foundation for the study of abnormalities in attention that can be seen in many brain disorders such as autism, schizophrenia, and attention deficit disorder.
Researchers have discovered a new approach to preventing or treating a stomach bacterium associated with an increased risk of stomach cancer as well as gastritis and duodenal ulcers.
› Verified 6 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
BELLUS Health Inc. announced today that, on March 30, 2010, the Company initiated a Phase I clinical study for NRM8499, a prodrug of tramiprosate. NRM8499 is intended for the treatment of Alzheimer's disease.
University of Utah (U of U) medical researchers have uncovered a wiring diagram that shows how the brain pays attention to visual, cognitive, sensory, and motor cues. The research provides a critical foundation for the study of abnormalities in attention that can be seen in many brain disorders such as autism, schizophrenia, and attention deficit disorder.
Researchers have discovered a new approach to preventing or treating a stomach bacterium associated with an increased risk of stomach cancer as well as gastritis and duodenal ulcers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Beth Sotsky, MD 9910 Franklin Square Dr Ste 2110, Baltimore, MD 21236-4902 Ph: (410) 933-6423 | Rachel Beth Sotsky, MD 4940 Eastern Ave, Baltimore, MD 21224-2735 Ph: (410) 550-0101 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
BELLUS Health Inc. announced today that, on March 30, 2010, the Company initiated a Phase I clinical study for NRM8499, a prodrug of tramiprosate. NRM8499 is intended for the treatment of Alzheimer's disease.
University of Utah (U of U) medical researchers have uncovered a wiring diagram that shows how the brain pays attention to visual, cognitive, sensory, and motor cues. The research provides a critical foundation for the study of abnormalities in attention that can be seen in many brain disorders such as autism, schizophrenia, and attention deficit disorder.
Researchers have discovered a new approach to preventing or treating a stomach bacterium associated with an increased risk of stomach cancer as well as gastritis and duodenal ulcers.
› Verified 6 days ago
Robert J Brumback, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
Dr. Milford Howarth Marchant Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 S Hanover St, Baltimore, MD 21225 Phone: 410-350-8336 Fax: 410-350-7178 | |
Dr. Michelle Ghert, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 110 S Paca St Fl 6, Baltimore, MD 21201 Phone: 614-397-2721 | |
Henry R Boucher, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
John J Carbone, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3001 S Hanover St, Gruehn Bldg, Ste 502, Baltimore, MD 21225 Phone: 410-350-8300 | |
Dr. Dawn Laporte, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Rm 5210, Baltimore, MD 21287 Phone: 410-955-3134 | |
Paul C Mcafee, M.D., MBA Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St Ste 655, Baltimore, MD 21218 Phone: 410-554-2175 Fax: 410-554-2917 |